Ask a brand or medical-affairs team to describe their KOL strategy and you often hear a list of names, not a programme. Engagement happens, a talk here, an advisory board there, but without a structure that connects touchpoints, sets objectives or measures impact. The relationships are real; the strategy is implied.
Map the right opinion leaders
A governed programme starts with segmentation: who influences prescribing and guidelines in each therapy area, at national, regional and digital levels, and what role each should play across the lifecycle.
Objectives per touchpoint
Every interaction, advisory board, publication, speaker programme, digital exchange, should carry a defined objective and a record. That is what makes engagement coherent across a year rather than a series of one-offs.
Compliance is the enabler
Under UCPMP, the documentation that makes a KOL programme auditable is the same documentation that makes it measurable. Governance and impact reinforce each other.
Connect to the field
KOL influence only pays off when it reaches the field. Linking opinion-leader activity to HCP engagement and prescription data closes the loop from science to prescribing.
How Ichelon helps
Our channel-engagement practice builds structured, Rx-linked KOL programmes, and Pharos RxFlow and Signal connect that influence to HCP-level engagement and prescription outcomes.
Ready to apply this thinking?
Start a pilot project and evaluate Ichelon's quality within one delivery cycle.